Filter by year:

Filter by tags:


Amicus Therapeutics to Present Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting

These represent the first set of preclinical results for the Pompe gene therapy which Amicus is currently developing in collaboration with the Gene Therapy Program of the Perelman School of Medicine at the University of Pennsylvania (Penn).


Scout Bio Announces $20 Million Financing to Advance Pipeline of One-time Therapies for Companion Animals

Company supported by leading life sciences investors and an R&D collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania


Dr Jim Wilson on the air at WJR Radio in Detroit

Dr Jim Wilson discussed the reasons he and his wife, Lisa, made a $5.1 million donation to Albion College to help change the way medical students are educated with Paul W Smith at WJR Radio in Detroit. Check out the March 26th podcast!


Penn’s Gene Therapy Vector Core Receives $13 Million, Five-Year Renewal from NIH

Virus-Based Program Supports Advancement of Translational, Gene-Therapy Research


Amicus Establishes Global Research and Gene Therapy Center of Excellence in Philadelphia

"...Amicus is working to pioneer significant advancements in gene therapy, which includes a collaboration with Dr. James Wilson and his team at our Orphan Disease Center. This relationship reflects how the innovation ecosystem at Penn brings together researchers, innovators, and entrepreneurs to accelerate research discoveries to patients as quickly as possible..." -Dr Larry Jameson, Executive Vice President for the Health System and Dean of the Raymond and Ruth Perelman School of Medicine


Christian Can See

Scientific pioneers Dr Jim Wilson, Dr Jean Bennett, and Dr Kathy High discuss their extraordinary research and the promise of gene therapy in an interview with former Speaker of the House Newt Gingrich.